Gene Query: MRPL11

Dataset Description Geneva Score
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 51.58
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 48.08
An RNA-centric dissection of host complexes controlling flavivirus infection 48.08
EWSR1 influences alternative splicing through direct and indirect mechanisms 27.6
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 24.79
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 24.12
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 22.46
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 20.82
Global analyses of the effect of different cellular contexts on microRNA targeting 20.82
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 20.43
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 20.18
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 19.93
Genome wide expression change in LCC2 and MCF-7 cells 19.71
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 19.6
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 19.5
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 19.12
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 19.12
The comparison of high-throughput single-cell RNA-seq methods 18.82
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 17.66
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 17.65
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 17.59
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 17.25
Rorc disruption in human FG pancreatic cancer cells 17.06
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 16.06
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 15.76
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 15.76
LncRNA-GAS5 negative regulation of YAP-target genes expression 15.73
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 15.53
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 15.36
hnRNP C is a key regulator of protein synthesis in mitosis 15.36
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 15.2
Total RNA-seq in ALL-SIL upon JQ1 inhibition 15.18
mRNA expression in iPS cells generated by a synthetic self-replicative RNA 14.97
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 14.79
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 14.1
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 14.05
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 13.89
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 13.88
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 13.87
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 13.48
Gene expression analysis of the impact of TDP-43 knockout in human cells. 13.47
MOF acetyl transferase regulates transcription and respiration in mitochondria 13.33
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 13.13
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 13.11
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 13.0
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 13.0
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 12.9
A549 cells and MSR-A549 cells 12.9
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 12.88
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 12.81
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 12.68
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 12.55
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 12.53
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 12.53
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 12.51
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 12.36
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 12.22
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 11.88
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 11.68
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 11.68
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 11.59
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 11.59
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 11.52
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 11.51
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 11.48
HNF1A deficiency impairs β-cell fate, granule maturation and function 11.42
Identification of transcription start sites for human A549 cell line using ReCappable-seq 11.39
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 11.36
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 11.11
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 11.11
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 11.06
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 11.0
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 10.77
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 10.73
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 10.63
RNAseq analysis of ESRP regulated splicing events in prostate cancer 10.57
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 10.52
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 10.45
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 10.45
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 10.38
Differential gene expression of human melanoma cells [RNA-seq] 10.38
RNA-seq of resting and activated CD4+ T cells +-JQ1 10.28
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 10.1
Human Treg IL-12 stimulation 10.0
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 9.89
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 9.76
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 9.76
RNA-seq analysis of RALD iPSCs after in vitro differentiation 9.66
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 9.63
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 9.63
Generating Patterned Kidney Organoids for Studying Development and Diseases 9.58
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 9.55
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 9.53
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 9.53
CROP-Seq in Primary Human T Cells 9.41
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 9.31
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 9.21
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 9.12
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 9.11
Global expression profiles in cardiac progenitor cells generated by ISX-9 9.1
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 9.1
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 9.03
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 8.98
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 8.97
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 8.97
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 8.97
Global analysis of enhancer targets: Mosaic-seq 8.95
Survival of pancreatic cancer cells lacking KRAS function 8.95
Trans-differentiation of human adult peripheral blood T cells into neurons 8.95
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 8.91
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 8.91
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 8.91
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 8.84
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 8.78
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 8.67
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 8.67
Transcriptome profiling of 5 human adenocarcinoma cell lines 8.62
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 8.57
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 8.57
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 8.53
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 8.51
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 8.45
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 8.45
Systematic discovery of endogenous human ribonucleoprotein complexes 8.38
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 8.37
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 8.35
KLF6-dependent transcription in renal cancer cells 8.34
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 8.23
Hijacking of stress response machinery by oncogenes in acute leukaemia 8.11
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 8.11
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 8.1
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 8.1
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 8.09
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 8.08
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 8.08
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 8.08
NRDE2 negatively regulates nuclear exosome functions 8.06
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 8.05
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 8.01
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 8.01
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 7.84
The landscape of alternative splicing in aggressive prostate cancers 7.79
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 7.73
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 7.63
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 7.58
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 7.58
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 7.57
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 7.44
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 7.44
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 7.43
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 7.42
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 7.41
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 7.36
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 7.36
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 7.3
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 7.29
Differentially expressed vascular development genes for iPSC-ECs from CDI 7.27
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 7.27
Lysine benzoylation is a novel histone mark 7.23
Lysine benzoylation is a novel histone mark [RNA-seq] 7.23
U1 snRNP telescripting regulates size-function stratified human genome 7.22
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 7.17
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 7.16
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 7.07
Tracking distinct RNA populations using efficient and reversible covalent chemistry 7.07
Transcriptome sequencing of K-562 cells 7.05
Regulation of poly(A) tail and translation during the somatic cell cycle 7.03
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 7.01
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 7.01
Patient-derived luminal breast cancer xenografts with progestins 7.0
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 7.0
Comprehensive comparative analysis of 5’ end RNA sequencing methods 6.95
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 6.94
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 6.9
Active translatome profiling with RiboLace in MCF7 cells 6.72
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 6.71
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 6.7
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 6.63
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 6.63
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 6.54
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 6.53
A map of gene expression in neutrophil-like cell lines 6.51
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 6.43
Transcriptome analysis of H9 hESC derived cerebral organoids 6.39
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone 6.39
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 6.38
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 6.38
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 6.36
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 6.36
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 6.36
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 6.34
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 6.33
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 6.3
hTERT promotes cell adhesion and migration independent of telomerase activity 6.28
Genome wide expression change by RNF168 knocking down in NEC cells 6.26
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 6.25
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 6.25
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 6.25
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 6.25
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 6.24
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 6.21
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 6.21
RNA-seq analyses of human prostate cancer cells 6.21
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 6.2
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 6.2
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 6.17
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 6.11
Glioblastoma stem cells infected by ZIKA virus 6.1
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 6.08
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 6.08
miRNAs affected by antagomiR-17 treatment 6.06
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 6.06
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 6.04
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 6.0
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 5.91
Regulation of protein translation during mitosis 5.91
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 5.89
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 5.89
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 5.86
Transcriptome-wide identification of CELF2 functional targets in T cells 5.85
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 5.79
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 5.77
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 5.7
Functional role of CPPED1 in trophoblasts. 5.64
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 5.64
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 5.59
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 5.58
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 5.53
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 5.48
Examining serotonergic neuron differentiation from human iPSCs 5.47
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 5.44
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 5.42
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 5.39
MCF-7 as a model for functional analysis of breast cancer risk variants 5.37
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 5.36
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 5.36
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 5.35
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 5.32
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 5.3
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 5.3
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 5.26
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 5.21
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 5.21
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 5.21
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 5.19
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 5.13
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 5.12
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 5.1
RNA-Seq with and without RNase treatment in PCa cell lines 5.05
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 5.05
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 5.0
High-throughput sequencing of PROMPT-enriched samples. 4.98
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 4.93
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 4.93
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 4.93
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 4.86
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 4.86
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 4.83
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 4.83
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 4.72
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 4.72
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 4.71
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 4.7
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 4.68
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 4.66
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 4.66
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 4.53
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 4.53
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 4.51
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 4.51
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 4.51
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 4.49
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 4.46
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 4.45
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 4.43
Genetic-to-epigenetic Therapy for Pancreatic Cancer 4.41
RNA editing in nascent RNA affects pre-mRNA splicing 4.4
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 4.26
CSL 4.15
CSL RNA-Seq on HKC and SCC cell lines 4.15
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 4.11
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 4.11
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 4.08
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 4.0
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 3.98
PRDM1 inhibits proliferation of human colon cancer organoids 3.96
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 3.96
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 3.92
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 3.92
Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AML 3.91
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 3.91
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 3.91
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 3.84
RNA seq with AML (NB4) cells upon FTO inhibition 3.77
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 3.76
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 3.73
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 3.72
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 3.7
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 3.67
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 3.66
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 3.64
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 3.62
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 3.59
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 3.58
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 3.57
The cohesin complex prevents Myc-induced replication stress 3.56
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 3.53
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 3.51
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 3.48
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 3.44
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 3.44
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 3.42
An siRNA screen identifies CHD4 as a target for epigenetic therapy 3.41
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 3.41
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 3.41
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 3.4
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 3.4
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 3.39
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 3.38
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 3.37
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 3.36
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 3.35
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 3.34
O-glcnAc reprograms cellular energetics 3.3
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 3.29
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 3.24
RNAseq of cell lines with knocked in ESR1 mutations 3.24
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 3.15
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 3.11
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 3.09
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 3.09
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 3.09
Gene expression and genome-wide location analysis of breast cancer cell-lines 3.08
Gene expression analysis of breast cancer cell-lines 3.08
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 3.06
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 3.06
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 3.06
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 3.02
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 3.02
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 3.0
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 2.97
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 2.97
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 2.94
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 2.94
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 2.94
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 2.93
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 2.93
NR2F2 study 2.93
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 2.9
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 2.89
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 2.89
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 2.86
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 2.83
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 2.83
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 2.81
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 2.8
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 2.8
RNA-Seq of PRMT1 overexpression ECA109 cells 2.73
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 2.68
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 2.67
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 2.66
MYCL and EP400 are required for Max and MCPyV mediated gene activation 2.64
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 2.63
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 2.62
Tracing Enhancer Networks using Epigenetic Traits (TENET) 2.55
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 2.51
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 2.49
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 2.45
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 2.38
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 2.35
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 2.27
MARS Seq data from human cortical organoids 2.25
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 2.25
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 2.24
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 2.23
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 2.22
The transcriptome effect of overexpressing EZH2 in MCF7 2.19
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 2.17
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 2.17
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 2.14
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 2.09
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 2.08
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 2.07
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 2.07
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 2.01
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 1.92
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 1.89
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 1.87
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 1.82
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 1.82
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 1.79
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 1.79
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 1.78
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 1.75
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 1.75
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 1.75
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 1.74
Effect of ILF3 on translation during homeostasis and the antiviral response 1.71
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 1.71
Gene expression profile in breast cancer cells 1.69
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 1.69
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 1.63
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 1.62
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 1.62
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 1.62
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 1.61
Metastasis in triple-negative breast cancer 1.61
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 1.61
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 1.58
Human Treg NaCl stimulation 1.58
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 1.58
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 1.49
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 1.48
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 1.47
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 1.46
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 1.44
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 1.44
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 1.38
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 1.38
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 1.37
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 1.36
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 1.32
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 1.3
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 1.26
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 1.2
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 1.19
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 1.17
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 1.16
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 1.14
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 1.09
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 1.05
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 1.05
Iron response of HepG2 cells 1.04
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 1.02
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 0.99
Effect of PRDM11 depletion in U2932 cells 0.99
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 0.99
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 0.99
Copper Regulation of HIF-1 Transcription Activity 0.99
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 0.96
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 0.96
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 0.96
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 0.95
Impact on erythroid progenitor type on erythroid differntiation 0.94
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.93
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 0.91
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.87
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 0.87
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 0.85
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 0.83
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.83
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 0.79
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 0.78
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 0.76
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 0.76
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 0.75
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 0.75
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 0.75
DRB/GRO-Seq -/+ UV 0.72
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 0.68
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 0.68
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq2] 0.67
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 0.65
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 0.65
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.62
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.62
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 0.62
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 0.56
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 0.54
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.53
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 0.52
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 0.52
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.5
4sUDRB-seq: measuring transcription elongation and initiation genomewide 0.47
Global transcriptome analysis of WT versus HEB-/- hESCs 0.47
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 0.46
HNRNPM-regulated splicing dependencies in prostate cancer 0.46
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 0.46
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.43
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.39
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.39
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 0.37
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 0.37
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.36
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.34
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 0.3
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.29
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 0.28
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 0.22
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 0.18
Genome-wide analysis of the Integrator complex 0.17
Genome-wide analysis of the Integrator complex (HTS) 0.17
FBXW7 modulates stress response by post-translational modification of HSF1 0.16
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 0.16
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.16
Function and hormonal regulation of GATA3 in human first trimester placentation 0.15
Myc activation coordinates gene transcription and protein translation responses 0.12
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 0.08
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.08
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation